Search

Search bills, members, committees and pages...

H.R. 1539

U.S. HouseIn House Committee

Summary

H.R. 1539, the Medical Device Electronic Labeling Act, was introduced in the House on Feb 24, 2025 by Rep. Jay Obernolte (R) with 7 co-sponsors. It was referred to Energy And Commerce, and last saw action on Feb 24, 2025: Referred to the House Committee on Energy and Commerce.


Record

Text

H.R. 1539 has 7 co-sponsors.

hb1539/introduced-in-house.txt
119 HR 1539 IH: Medical Device Electronic Labeling Act
U.S. House of Representatives
2025-02-24
text/xml
EN
Pursuant to Title 17 Section 105 of the United States Code, this file is not subject to copyright protection and is in the public domain.
I 119th CONGRESS 1st Session H. R. 1539 IN THE HOUSE OF REPRESENTATIVES February 24, 2025 Mr. Obernolte (for himself, Mr. Mullin , Mr. Crenshaw , and Ms. Craig ) introduced the following bill; which was referred to the Committee on Energy and Commerce A BILL
To amend the Federal Food, Drug, and Cosmetic Act to expand the types of devices for which required labeling may be made available solely by electronic means, and for other purposes.
1.
Short title
This Act may be cited as the Medical Device Electronic Labeling Act .
2.
Allowing required labeling of devices to be made available solely by electronic means
Section 502(f) of the Federal Food, Drug, and Cosmetic Act ( 21 U.S.C. 352(f) ) is amended to read as follows:
(f)
(1)
Unless its labeling bears (A) adequate directions for use; and (B) such adequate warnings against use in those pathological conditions or by children where its use may be dangerous to health, or against unsafe dosage or methods or duration of administration or application, in such manner and form, as are necessary for the protection of users, except that where any requirement of clause (A) of this subparagraph, as applied to any drug or device, is not necessary for the protection of the public health, the Secretary shall promulgate regulations exempting such drug or device from such requirement.
(2)
Subject to subparagraph (3), required labeling for devices (including in vitro diagnostic devices) may be made available solely by electronic means, provided that—
(A)
such required labeling is readily accessible to intended users of such devices;
(B)
the manufacturer affords intended users of such devices the opportunity to request the required labeling in paper form, and upon such request, promptly provides the requested information in paper form without additional cost; and
(C)
the label affixed to the device or its immediate container includes all information in compliance with this Act and the regulations thereunder or any applicable order of the Secretary under subparagraph (3)(A).
(3)
(A)
With respect to devices for which labeling is made available solely by electronic means, the Secretary may issue an order establishing requirements in addition to, or exceptions from, the requirements under subparagraph (2) for the label affixed to a device type.
(B)
Notwithstanding subchapter II of chapter 5 of title 5, United States Code, such order shall be published in the Federal Register, following publication of a proposed order in the Federal Register and consideration of comments to a public docket.
(C)
Such order may require the label of a device to contain certain information or comply with certain conditions only if the Secretary determines such requirement is necessary to provide a reasonable assurance of the safety and effectiveness of the device.
.

Tracker

The tracker indicates the progress of this legislation as it moves through the legislative process.

  1. Introduced2025-02-24
  2. Passed House
  3. Passed Senate
  4. Conference
  5. To President
  6. Became Law

CRS Summary

The summaries are the Congressional Research Service’s, one per stage. Read them in full.

Introduced in House Feb 24, 2025

hb1539/introduced-in-house.md

Shown Here:
Introduced in House (02/24/2025)

Medical Device Electronic Labeling Act

This bill expands the permitted use of electronic labeling of medical devices to allow directions for use and warning labels for all medical devices to be provided electronically, rather than physically (i.e., affixed to or accompanying the device or its container).

(Under current law, direction and warning labels may be provided electronically only for (1) prescription devices intended for use in health care facilities or by health care professionals, and (2) in vitro diagnostic devices intended for use in blood establishments or by health care professionals.)

Under the bill, direction and warning labels may be provided solely electronically for all medical devices so long as (1) the electronic label is readily accessible to the device’s intended users, (2) intended users may request a paper label at no additional cost, and (3) the label affixed to the device or its packaging contains all information required under current laws and regulations.

The Food and Drug Administration may issue regulations establishing additional requirements or exceptions to these provisions.

Sponsors

Rep. Jay Obernolte (R) sponsors H.R. 1539, and 7 members have co-sponsored it, 3 of them from the day it was introduced.

Committees

H.R. 1539 went before 1 committee: Energy and Commerce.

Energy and Commerce
Energy and Commerce
Referred To · Feb 24, 2025 · 1,636 Bills

Actions

H.R. 1539 has taken 2 actions since Feb 24, 2025.

ChamberAction
Feb 24, 2025
House
Introduced in House
Feb 24, 2025
House
Referred to the House Committee on Energy and Commerce.Energy and Commerce Committee

Votes

H.R. 1539 has not gone to a roll call.

Titles

H.R. 1539 goes by 3 titles, 1 of them short titles.

  • Medical Device Electronic Labeling Act — Display Title
  • Medical Device Electronic Labeling Act — Short Title(s) as Introduced
  • To amend the Federal Food, Drug, and Cosmetic Act to expand the types of devices for which required labeling may be made available solely by electronic means, and for other purposes. — Official Title as Introduced

Lobbying

10 clients hired 10 firms and 67 registered lobbyists who named H.R. 1539 in 34 quarterly filings, 2025 to 2026. Reported under the Lobbying Disclosure Act; a filing’s income covers everything its registrant worked that quarter, so the amounts below are the filings’, not this bill’s.

Filed under Health Issues, Taxation/Internal Revenue Code, Medicare/Medicaid, Trade (domestic/foreign), Budget/Appropriations, Veterans, Copyright/Patent/Trademark, Defense.

Clients

Who paid to be heard, by how many filings named the bill.

ClientBusinessStateFirmsFilingsReported
DEXCOM, INC.California16
JOHNSON & JOHNSON SERVICES INCNew Jersey16
MEDTRONIC INCDistrict of Columbia16
ADVANCED MEDICAL TECHNOLOGY ASSNDistrict of Columbia14
THE COOK GROUP INC.Virginia14
MEDICAL DEVICE MANUFACTURERS ASSOCIATIONTrade association for medical device manufacturers.District of Columbia13$60K
PHILIPS HOLDING USA INC.Massachusetts12
AMERICAN MEDICAL ASSOCIATIONDistrict of Columbia11
BREAKTHROUGH T1D (FORMERLY KNOWN AS JDRF INTL.)District of Columbia11
ZIMMER BIOMET, INC.District of Columbia11

Firms

Registrants who filed on the bill, by filings.

Lobbyists

Named on the filings that cite the bill. The 20 named most often, of 67.

Filings

The documents themselves, on the Senate’s Lobbying Disclosure site, largest reported first.

ClientRegistrantPeriodReportedDocument
AMERICAN MEDICAL ASSOCIATIONAMERICAN MEDICAL ASSOCIATION2025 first_quarter$8M1st Quarter - Report
JOHNSON & JOHNSON SERVICES INCJOHNSON & JOHNSON SERVICES, INC.2026 first_quarter$3.5M1st Quarter - Report
JOHNSON & JOHNSON SERVICES INCJOHNSON & JOHNSON SERVICES, INC.2025 first_quarter$3.3M1st Quarter - Report
JOHNSON & JOHNSON SERVICES INCJOHNSON & JOHNSON SERVICES, INC.2025 third_quarter$2.5M3rd Quarter - Report
MEDTRONIC INCMEDTRONIC, INC.2025 third_quarter$2.1M3rd Quarter - Report
JOHNSON & JOHNSON SERVICES INCJOHNSON & JOHNSON SERVICES, INC.2025 fourth_quarter$1.5M4th Quarter - Report
JOHNSON & JOHNSON SERVICES INCJOHNSON & JOHNSON SERVICES, INC.2026 second_quarter$1.4M2nd Quarter - Report
MEDTRONIC INCMEDTRONIC, INC.2026 second_quarter$1.2M2nd Quarter - Report
ADVANCED MEDICAL TECHNOLOGY ASSNADVANCED MEDICAL TECHNOLOGY ASSN2026 first_quarter$1.1M1st Quarter - Report
JOHNSON & JOHNSON SERVICES INCJOHNSON & JOHNSON SERVICES, INC.2025 second_quarter$1M2nd Quarter - Report
MEDTRONIC INCMEDTRONIC, INC.2025 fourth_quarter$990K4th Quarter - Report
ADVANCED MEDICAL TECHNOLOGY ASSNADVANCED MEDICAL TECHNOLOGY ASSN2026 second_quarter$971K2nd Quarter - Report
MEDTRONIC INCMEDTRONIC, INC.2025 first_quarter$970K1st Quarter - Report
ADVANCED MEDICAL TECHNOLOGY ASSNADVANCED MEDICAL TECHNOLOGY ASSN2025 fourth_quarter$942K4th Quarter - Report
MEDTRONIC INCMEDTRONIC, INC.2026 first_quarter$940K1st Quarter - Report
ADVANCED MEDICAL TECHNOLOGY ASSNADVANCED MEDICAL TECHNOLOGY ASSN2025 third_quarter$860K3rd Quarter - Report
PHILIPS HOLDING USA INC.PHILIPS HOLDING USA, INC.2025 second_quarter$720K2nd Quarter - Report
MEDTRONIC INCMEDTRONIC, INC.2025 second_quarter$650K2nd Quarter - Report
PHILIPS HOLDING USA INC.PHILIPS HOLDING USA, INC.2026 second_quarter$640K2nd Quarter - Report
DEXCOM, INC.DEXCOM, INC.2025 fourth_quarter$390K4th Quarter - Report

Classification

The Congressional Research Service files H.R. 1539 under Health, one of its 31 policy areas, and gives it 3 legislative subjects.

CRS Subjects

CRS assigns every bill one policy area from its 31; H.R. 1539’s is Health.

hr1539/policy-areas.txt
HealthAgriculture and FoodAnimalsArmed Forces and National SecurityArts, Culture, ReligionCivil Rights and Liberties, Minority IssuesCommerceCongressCrime and Law EnforcementEconomics and Public FinanceEducationEmergency ManagementEnergyEnvironmental ProtectionFamiliesFinance and Financial SectorForeign Trade and International FinanceGovernment Operations and PoliticsHousing and Community DevelopmentImmigrationInternational AffairsLabor and EmploymentLawNative AmericansPublic Lands and Natural ResourcesScience, Technology, CommunicationsSocial WelfareSports and RecreationTaxationTransportation and Public WorksWater Resources Development

Legislative Subjects

H.R. 1539 carries 3 of CRS’s legislative subjects, from Computers and information technology to Drug safety, medical device, and laboratory regulation.

hr1539/subjects.txt
Computers and information technologyConsumer affairsDrug safety, medical device, and laboratory regulation

Constitutional authority

The clause the sponsor cites as Congress’s power to enact H.R. 1539, as entered in the Congressional Record.

[Congressional Record Volume 171, Number 36 (Monday, February 24, 2025)][House]From the Congressional Record Online through the Government Publishing Office [www.gpo.gov]By Mr. OBERNOLTE:H.R. 1539.Congress has the power to enact this legislation pursuantto the following:Article 1 section 8[Page H769]

Source: congress.gov · legiscan.com